Your prediction
Pros and Cons of ALS Ltd in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ALS Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ALS Ltd | - | 0.637% | 1.935% | 3.268% | 1.282% | 17.037% | 61.126% |
| Seek Ltd | 0.680% | 2.759% | 1.361% | 2.055% | -9.697% | -23.980% | 42.040% |
| Downer EDI Ltd | - | -0.725% | -4.861% | 26.852% | 9.600% | -23.034% | -42.473% |
| Western Union Co. | 0.900% | -0.857% | 0.273% | 13.134% | 15.863% | -40.410% | -26.856% |
News
These biotechs targeting multiple neurodegenerative diseases
Anyone who has struggled with a neurodegenerative disease (NDD) or has cared for someone who has one of these illnesses knows how challenging they are to treat and even diagnose. NDDs damage
